Melexis posts in-line Q3 results, maintains H2 guidance

Melexis reported Q3 revenue of €224 million, in line with consensus, while adjusted EPS of €0.78 missed the €0.83 estimate and EBIT margin of 18.5% fell short of 18.9%. The company maintained second-half 2026 revenue guidance of €445–455 million, whose €450 million midpoint is slightly below the €451.1 million consensus, and expects an approximately 18% EBIT margin versus 18.5% consensus. Robotics design wins began ramping into volume earlier than expected, and Melexis signed a master purchase agreement with BYD.

Analysis

The key signal is weaker conversion of sales into profit, not demand: an EPS miss and lower-than-expected EBIT-margin outlook point to operating leverage or mix/cost pressure even as revenue holds. If that persists, investors may discount the apparent inventory normalization until margins stabilize. Robotics is a potential offset, but early customer production can pull revenue forward; the next proof point is sustained volume and incremental margin contribution, not design wins alone.

Over 1–3 months, watch for revisions to EBIT-margin expectations and evidence that robotics shipments add to, rather than substitute for, existing programs. BYD’s purchase agreement and localized China production could improve customer access and resilience to localization requirements, but neither establishes material near-term revenue. Localization may also bring execution, IP, and geopolitical risks. Over 6–18 months, rising sensor content per vehicle and robotics/industrial diversification could support growth, while automotive concentration and pricing pressure remain the counterweight. Competitors such as Infineon, STMicroelectronics, NXP, and Allegro MicroSystems may face greater competition for sensor content, though the article provides no evidence of displaced programs.

The contrarian upside is that normalized inventories plus earlier robotics ramps may mark a better volume inflection than the cautious margin outlook implies. Conversely, treating one early ramp as a durable growth engine is premature. No valuation or share-price data is provided, so a valuation-based buy/sell call is not supportable.

Key Decisions for Investors

• Near term: avoid chasing MELE on robotics headlines; consider trimming into strength rather than initiating a short without valuation and price context. The earnings-quality signal is modestly negative, not a demonstrated demand break.
• Over the next 1–3 months, monitor reported EBIT margin, full-year guidance revisions, and whether robotics volumes recur. A further margin-guide cut or missed volume ramp would strengthen the cautious view; sustained margin near guidance with repeat shipments would falsify it.
• Treat BYD and China localization as watch items, not booked-growth catalysts. Verify disclosed revenue contribution, production scale, customer concentration, and localization costs before assigning a material earnings premium.
• For a relative-value screen, compare MELE’s margin and growth revisions with Infineon, STMicroelectronics, NXP, and Allegro MicroSystems; do not assume direct substitution or construct a pair trade until relative valuation and exposure data are checked.